Founded in 2010, LNC Therapeutics is a French biotech company specialized in gut microbiome-based drug discovery. All of the company's projects include basic research, preclinical research and clinical trials. Backed by leading venture capital investors, such as Seventure Partners (with the microbiome dedicated vehicle Health for Life Capital) and Family Offices, the company cultivates worldwide collaborations with renowned medical experts to ensure the highest level of standards in the development of innovative drugs. With a total of 16.5 million raised so far including 1.5 million grants from French BPI and Aquitaine Region, LNC Therapeutics will pursue its research programs to bring the next generation approach to treat obesity and cardiometabolic diseases. For more information, please visit www.lnctherapeutics.com. Follow us on Twitter @LNCTherapeutics
Founded in 2010, LNC Therapeutics is a French biotech company specialized in gut microbiome-based drug discovery. All of the company's projects include basic research, preclinical research and clinical trials. Backed by leading venture capital investors, such as Seventure Partners (with the microbiome dedicated vehicle Health for Life Capital) and Family Offices, the company cultivates worldwide collaborations with renowned medical experts to ensure the highest level of standards in the development of innovative drugs. With a total of 16.5 million raised so far including 1.5 million grants from French BPI and Aquitaine Region, LNC Therapeutics will pursue its research programs to bring the next generation approach to treat obesity and cardiometabolic diseases. For more information, please visit www.lnctherapeutics.com. Follow us on Twitter @LNCTherapeutics